Navigation Links
Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
Date:10/31/2013

of business, the impact of currency fluctuations, amortization and other non-cash charges, amortization including intangible asset impairments and write-down of deferred financing costs, debt discounts and ASC 470-20 (FSP APB 14-1) interest, loss on extinguishment of debt, (gain) loss on assets held for sale/impairment, net, (gain) loss on investments, net, and adjusts tax expense to cash taxes. Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a meaningful, consistent comparison of the company's core operating results and trends for the periods presented. Non-GAAP financial measures are not prepared in accordance with GAAP.  Therefore, the information is not necessarily comparable to other companies and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

Financial Tables follow. Valeant Pharmaceuticals International, Inc. Table 1 Condensed Consolidated Statements of Income (Loss)For the Three and Nine Months Ended September 30, 2013 and 2012Three Months EndedNine Months EndedSeptember 30,September 30,(In thousands, except per share data)2013201220132012Product sales$ 1,506,421$ 852,747$ 3,608,801$ 2,346,599Alliance and royalty16,47112,24839,651148,348Service and other18,83919,14557,39665,386Total revenues1,541,731884,1403,705,8482,560,333Cost of goods sold (exclusive of amortization of intangible assets shown separately below)560,855216,4941,128,942633,618Cost of services13,58013,75842,55749,417Cost of alliances773-1,68468,820Selling, general and administrative ("SG&A")355,637188,660854,909551,386Research and development
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 Clinicient Inc , ... announced the results of an industry survey of ... 759 therapists, practice owners and administrative staff completed ... need for technology and services that improve therapist ... findings, Clinicient published a free 12-page guide to ...
(Date:5/26/2015)... 26, 2015  EndoChoice today announced the launch of ... common stock, which will represent 25.6% of its outstanding ... Delaware corporation in connection with the offering. ... be between $15 and $17 per share. The underwriters ... to purchase up to an additional 937,500 shares of ...
(Date:5/26/2015)... LONDON , May 26, 2015 ... that technology,s commercial potential ,What,s the future of ... and commercial predictions from 2015. Stay ahead there ... tests, you explore sales results, R&D, opportunities and ... visiongain shows you what,s possible for ...
Breaking Medicine Technology:Survey: Half of Physical Therapists Underbill For Their Services 2EndoChoice Announces Launch of Its Initial Public Offering 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
... Calif., March 7, 2011 Bionovo, Inc. (Nasdaq: ... development of safe and effective treatments for women,s health and ... Chief Executive Officer, will be presenting at the Cowen and ... Wednesday, March 9, 2011. The event will be held at ...
... YORK, March 7, 2011 The Rottenstein Law Group, which ... hip replacement devices manufactured and sold by DePuy Orthopaedics, is ... carefully the safety of metal-on-metal joint implants. At ... www.fda.gov , the U.S. Food and Drug Administration states the ...
Cached Medicine Technology:Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference 2Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall 2
(Date:5/27/2015)... Get Tested Coachella Valley , ... spread of HIV, will recognize its most influential, passionate ... Social Ambassador Awards, to be held on Twitter on ... A first for public health campaigns, the online awards ... online influencers for breaking down stigma, spreading awareness and ...
(Date:5/27/2015)... 2015 One of America's most cherished ... of “In America” that takes a look at the ... described as an abnormal heart rhythm. Those who suffer ... irregularly or much too quickly. , This new segment ... in an effort to inform viewers about possible signs ...
(Date:5/27/2015)... 2015 According to research conducted by ... Center at Dallas some migraine patients have an increased ... migraine headache apparently also have some shared risk factors ... people with a history of diabetes and/or smoking. Both ... and CTS in particular was less common in Hispanics. ...
(Date:5/27/2015)... 27, 2015 HomeTown Health, along with ... north Georgia cities on May 13 & 14. In ... physicians to meet with the group of representatives and ... and office staff attended. , Referred to as ... to bring together Health Information Technology and ICD-10 resources ...
(Date:5/27/2015)... May 27, 2015 The Advanced Fertility Center ... is open for business to better serve the needs of ... Jefferson Park neighborhood on the Northwest side of the city ... can be arranged by calling the Chicago office at (773) ... Advanced Fertility Center of Chicago. The other 2 offices ...
Breaking Medicine News(10 mins):Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 2Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2
... MKL ) reported diluted net loss per share ... to diluted net income per share of $9.26,for the ... was $2.63 for the,nine months ended September 30, 2008 ... the same period of 2007. The results for both ...
... more targeted prevention efforts, researcher says , , TUESDAY, Nov. 4 ... Hispanics in the United States, a new study shows. , ... a type of beverage that is more associated with risky ... developed to target that beverage and that type of drinking," ...
... HAVEN, Conn., Nov. 4 VION,PHARMACEUTICALS, INC. (OTC Bulletin ... on Thursday, November 6, 2008 to,discuss its 2008 third ... 8:30 a.m. Eastern Time., To participate in the ... 213-8858 for international callers), at least 15 minutes,before the ...
... 4, 2008 Proactive measures can reduce hip fracture rates ... as 50 percent -- among those at risk, according to ... was published online on November 3 by The Journal ... , The largest study of its kind, the five-year study ...
... be Held at 8 a.m. EST -, SHENZHEN, ... (NYSE: NPD ) ("China Nepstar" or the "Company"), ... of directly operated,stores, announced today that the Company will ... before the market opens on,Wednesday, November 26, 2008., ...
... (Nasdaq: IRIX ) today reported financial results for ... the third quarter of 2008 was $12.0 million, an ... quarter of 2007. The,Company recorded net loss of $0.2 ... of 2008, an improvement over the net loss of ...
Cached Medicine News:Health News:Markel Reports Third Quarter and Nine-Month Results 2Health News:Markel Reports Third Quarter and Nine-Month Results 3Health News:Markel Reports Third Quarter and Nine-Month Results 4Health News:Study Shows Hispanics Prefer Beer 2Health News:Vion Updates Conference Call Information 2Health News:Vion Updates Conference Call Information 3Health News:Healthy bones program reduces hip fractures by 37 percent 2Health News:China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26 2Health News:China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26 3Health News:IRIDEX Reports Third Quarter 2008 Financial Results 2Health News:IRIDEX Reports Third Quarter 2008 Financial Results 3Health News:IRIDEX Reports Third Quarter 2008 Financial Results 4Health News:IRIDEX Reports Third Quarter 2008 Financial Results 5Health News:IRIDEX Reports Third Quarter 2008 Financial Results 6
Used for intermittent self-catheterization of the urethra. The flared proximal end allows the attachment of a syringe for bladder irrigation. Supplied sterile in peel-open packages. Reusable. Intende...
... test for the detection and semi-quantitation ... human serum. ANCA are found in ... vasculitides and hence, serve as an ... laboratory findings in the diagnosis of ...
... The Jerome Halo Vest is engineered to ... of the sternum and upper back, to maximize ... density polyethylene vest shell is readily conformable to ... fit. A natural lambs wool liner is ...
... an option beyond traditional methods for ... low back pain. The new Orthotrac,Pneumatic ... chronic back pain. In fact, associated ... of application.,The Orthotrac is the only ...
Medicine Products: